This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Merriman Curhan Ford Acted As Placement Agent In GenVec's $28 Million Registered Offering

SAN FRANCISCO, Feb. 1 /PRNewswire-FirstCall/ -- Merriman Curhan Ford (Nasdaq: MERR) acted as a placement agent in GenVec, Inc.'s (Nasdaq: GNVC) $28 million registered offering of 14 million shares of common stock, and warrants to purchase 4.2 million shares of common stock,  to certain institutional investors. The transaction closed today.

(Logo:  http://www.newscom.com/cgi-bin/prnh/20090911/MCFLOGO)

"We have been working with the Merriman team for several years and appreciate their continued efforts in advising GenVec on its financing activities," said Douglas Swirsky, Chief Financial Officer of GenVec.

The pricing of the offering was announced on January 27, 2010 by GenVec. Details on the transaction can be found at GenVec's Web site: www.genvec.com.

A bout G e n V ec

GenVec, Inc. is a biopharmaceutical company developing novel therapeutic drugs and vaccines. GenVec's lead product, TNFerade™, is currently in a pivotal clinical study (PACT) in locally advanced pancreatic cancer. TNFerade has also been and is currently being evaluated for its potential use in the treatment of several other cancers, including esophageal cancer, rectal cancer, and head and neck cancer. In addition, GenVec uses its proprietary  adenovector technology  to develop vaccines for infectious diseases including influenza, HIV, malaria, foot-and-mouth disease, respiratory syncytial virus (RSV), and HSV-2. GenVec also discovers and develops novel treatments for hearing loss and balance disorders through a worldwide collaboration with Novartis. Additional information about GenVec is available at www.genvec.com and in the company's various filings with the Securities and Exchange Commission.

Ab o u t M e rr i man Cu r h an F o rd

Merriman Curhan Ford (NASDAQ: MERR) is a financial services firm focused on fast-growing companies and the institutions that invest in them. The company offers high-quality investment banking, equity research, institutional services and corporate & venture services, and specializes in five growth industry sectors: CleanTech, Consumer, Media & Internet, Health Care, Natural Resources and Technology.  For more information, please go to www.mcfco.com.

N ote t o I n v es t ors

T his p re s s r e le a se c o nt a ins cer t ain for w a rd - lo o king s t a te m e n ts b a sed o n our cu r r e nt e x pe c ta t io n s, f o re c as t s a nd assu m p t io n s t h at inv o l v e r i sks a n d un c er t ai n t i es.   T h is re l ease does not con s t i t u te an o f fer to s e l l or a s o l i c i t a tion of o f f ers to buy any sec u r i t i es o f t h e C o m pany. F or w a rd - loo k i n g st a te m e n ts in th i s r e le a se are b a sed on i n for m a ti o n a va i lab l e to us as of the da t e he r eo f . O ur a ctu a l r e su l ts m a y d i f f er m a t eri a l l y f rom t h ose st a ted or i m p l ied in s u ch f or w ar d - l o oking st a te m e n ts, d u e t o r i sks and unce r t a in t ies ass o ci a ted w i th our bu s ine s s, w h ich in cl ude t h e r isk fa c to r s d i s c lo s ed in o ur F orm 10- K /A f i l ed on A p r i l 30, 2009 a nd o u r F orm 1 0 -Q f i led on N o v e m ber 1 6, 2 009. F or w a r d - loo k ing st a t e m ents in c lude st a te m e n ts reg a rd i ng our e xp e ct a ti o ns, b e l ie fs , in t en t io n s or st r at e gi e s r e gard i ng t h e f ut u re and can be i d en t i f ied by f o r w ar d -lo o ki n g w ords s uch as "a n ti c ip a te , " " be l i ev e," " co u ld," " e s t i m at e ," "e x pect , " " i n tend , " " m ay," "s h ould , " " w i l l," and " w o u ld" or s i m i lar w o r ds. W e assu m e no o b l iga t i o n to u p da t e t h e i n for m a t i on in c luded in th i s p r ess r e le a se, w h e ther as a r e su l t o f new in f or m a ti on, f u tu r e e v en t s or o th e r w i se. T he F orm 1 0 - K /A f i led on A pr i l 30, 2009 a nd F o r m 10-Q f il e d on N ove m b e r 16, 2 009, to g eth e r w i th t his pr e ss r e l ea s e and t he fin a nc i al in f or m a tion co n tai n ed h er e in, is a v ail a ble on our w eb s i t e by goi n g to w w w . m cfco. c om and c l i c k ing o n "I n ve s tor R el a t i ons . "

SOURCE Merriman Curhan Ford

Copyright 2009 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,077.57 -35.97 -0.21%
S&P 500 1,984.05 +0.52 0.03%
NASDAQ 4,463.0030 +6.9870 0.16%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs